TY - JOUR
T1 - Stable expression of human β1,4-galactosyltransferase in plant cells modifies N-linked glycosylation patterns
AU - Palacpac, Nirianne Q.
AU - Yoshida, Shohei
AU - Sakai, Hiromi
AU - Kimura, Yoshinobu
AU - Fujiyama, Kazuhito
AU - Yoshida, Toshiomi
AU - Seki, Tatsuji
PY - 1999/4/13
Y1 - 1999/4/13
N2 - β1,4-Galactosyltransferase (UDP galactose: β-N-acetylglucosaminide: β1,4-galactosyltransferase; EC 2.4.1.22) catalyzes the transfer of galactose from UDP-Gal to N-acetylglucosamine in the penultimate stages of the terminal glycosylation of N-linked complex oligosaccharides in mammalian cells. Tobacco BY2 cells lack this Golgi enzyme. To determine to what extent the production of a mammalian glycosyltransferase can alter the glycosylation pathway of plant cells, tobacco BY2 suspension-cultured cells were stably transformed with the full-length human galactosyltransferase gene placed under the control of the cauliflower mosaic virus 35S promoter. The expression was confirmed by assaying enzymatic activity as well as by Southern and Western blotting. The transformant with the highest level of enzymatic activity has glycans with galactose residues at the terminal nonreducing ends, indicating the successful modification of the plant cell N- glycosylation pathway. Analysis of the oligosaccharide structures shows that the galactosylated N-glycans account for 47.3% of the total sugar chains. In addition, the absence of the dominant xylosidated- and fucosylated-type sugar chains confirms that the transformed cells can be used to produce glycoproteins without the highly immunogenic glycans typically found in plants. These results demonstrate the synthesis in plants of N-linked glycans with modified and defined sugar chain structures similar to mammalian glycoproteins.
AB - β1,4-Galactosyltransferase (UDP galactose: β-N-acetylglucosaminide: β1,4-galactosyltransferase; EC 2.4.1.22) catalyzes the transfer of galactose from UDP-Gal to N-acetylglucosamine in the penultimate stages of the terminal glycosylation of N-linked complex oligosaccharides in mammalian cells. Tobacco BY2 cells lack this Golgi enzyme. To determine to what extent the production of a mammalian glycosyltransferase can alter the glycosylation pathway of plant cells, tobacco BY2 suspension-cultured cells were stably transformed with the full-length human galactosyltransferase gene placed under the control of the cauliflower mosaic virus 35S promoter. The expression was confirmed by assaying enzymatic activity as well as by Southern and Western blotting. The transformant with the highest level of enzymatic activity has glycans with galactose residues at the terminal nonreducing ends, indicating the successful modification of the plant cell N- glycosylation pathway. Analysis of the oligosaccharide structures shows that the galactosylated N-glycans account for 47.3% of the total sugar chains. In addition, the absence of the dominant xylosidated- and fucosylated-type sugar chains confirms that the transformed cells can be used to produce glycoproteins without the highly immunogenic glycans typically found in plants. These results demonstrate the synthesis in plants of N-linked glycans with modified and defined sugar chain structures similar to mammalian glycoproteins.
UR - http://www.scopus.com/inward/record.url?scp=0033551250&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033551250&partnerID=8YFLogxK
U2 - 10.1073/pnas.96.8.4692
DO - 10.1073/pnas.96.8.4692
M3 - Article
C2 - 10200324
AN - SCOPUS:0033551250
SN - 0027-8424
VL - 96
SP - 4692
EP - 4697
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 8
ER -